Skip to main content
. 2019 Dec;25(12):10.18553/jmcp.2019.25.12.1377. doi: 10.18553/jmcp.2019.25.12.1377

TABLE 1.

Baseline Characteristics of the Study Sample of Adult Participants with Chronic Liver Disease by Hemochromatosis Status Before and After Matchinga

Patient Characteristics Unmatched Matchedb
Hemochromatosis (n = 37,237) No Hemochromatosis (n = 580,659) Standardized Differencec Hemochromatosis (n = 37,092) No Hemochromatosis (n = 37,092) Standardized Differencec
Age, mean (SD) 47.09 (11.32) 48.82 (10.77) 0.1574 47.09 (11.31) 47.17 (11.27) 0.0065
Age group, years, n (%) 0.1506 0.0069
  18-34 5,623 (15.1) 68,387 (11.8) 5,592 (15.1) 5,504 (14.8)
  35-44 7,856 (21.1) 108,384 (18.7) 7,827 (21.1) 7,835 (21.1)
  45-54 12,251 (32.9) 188,462 (32.5) 12,204 (32.9) 12,224 (33.0)
  55+ 11,507 (30.9) 215,426 (37.1) 11,469 (30.9) 11,529 (31.1)
Gender, n (%) 0.0179 0.0023
  Male 17,337 (46.6) 275,530 (47.5) 17,271 (46.6) 17,228 (46.5)
  Female 19,900 (53.4) 305,129 (52.6) 19,821 (53.4) 19,864 (53.6)
Region of residence, n (%) 0.1417 0.0055
  Northeast 9,329 (25.1) 126,950 (21.7) 9,285 (25.0) 9,290 (25.1)
  North Central 7,325 (19.7) 103,548 (17.8) 7,296 (19.7) 7,301 (19.7)
  South 12,229 (32.8) 229,570 (39.5) 12,180 (32.8) 12,225 (330)
  West 7,542 (20.3) 109,865 (18.9) 7,523 (20.3) 7,494 (20.2)
  Unknown 812 (2.2) 10,726 (1.9) 808 (2.2) 782 (2.1)
Type of health insurance, n (%) 0.1113 0.0155
  Unknown 1,277 (3.4) 20,366 (3.5) 1,265 (3.4) 1,247 (3.36)
  Comprehensive 779 (2.1) 16,647 (2.8) 773 (2.1) 767 (2.1)
  Exclusive provider organization 764 (2.1) 9,871 (1.7) 759 (2.1) 746 (2.0)
  Health maintenance organization 3,881 (10.4) 75,695 (13.0) 3,855 (10.4) 3,886 (10.5)
  Non-capitated point-of-service 2,869 (7.7) 44,680 (7.7) 2,861 (7.7) 2,829 (7.6)
  Preferred provider organization 23,815 (64.0) 354,427 (61.0) 23,752 (64.0) 23,859 (64.3)
  Point-of-service with capitation 169 (0.5) 2,503 (0.4) 169 (0.5) 140 (0.4)
  Consumer-driven health plan 2,182 (5.9) 37,395 (6.4) 2,168 (5.8) 2,179 (5.9)
  High-deductible health plan 1,501 (4.0) 19,075 (3.3) 1,490 (4.0) 1,439 (3.9)
Comorbidity profiled
  Charlson Comorbidity Index score, mean (SD) 0.69 (1.36) 1.12 (1.82) 0.2658 0.69 (1.36) 0.71 (1.46) 0.0125
  Charlson Comorbidity Index score, n (%) 0.2975 0.0049
    0 24,372 (65.5) 301,235 (51.9) 24,281 (65.5) 24,305 (65.5)
    1 7,033 (18.9) 136,867 (23.6) 6,999 (18.8) 7,028 (19.0)
    2 2,848 (7.6) 57,624 (9.9) 2,838 (7.6) 2,807 (7.6)
    3 1,423 (3.8) 38,098 (6.6) 1,418 (3.8) 1,421 (3.8)
    4+ 1,561 (4.2) 46,835 (8.1) 1,556 (4.2) 1,531 (4.1)
  Type 2 diabetes, n (%) 5,453 (14.6) 139,698 (24.1) 0.2400 5,432 (14.6) 5,452 (14.7) 0.0015
  Arthritis, n (%) 15,483 (41.6) 264,306 (45.5) 0.0795 15,415 (41.6) 15,430 (41.6) 0.0008
Alcohol abuse or dependence, n (%) 199 (0.5) 7,970 (1.4) 0.0863 198 (0.5) 170 (0.5) 0.0107
  Myocardial infarction, n (%) 280 (0.8) 8,893 (1.5) 0.0734 280 (0.8) 255 (0.8) 0.0080

aAll demographics data were obtained on index date (first diagnosis date of hemochromatosis for cases and a randomly selected date from all claim records for controls).

bHemochromatosis cases and hemochromatosis-free controls were matched 1:1 using propensity score. The logistic regression model used to estimate propensity scores included age; region of residence; gender; type of health insurance; Charlson Comorbidity Index score (excluding myocardial infarction, rheumatic disease, diabetes without chronic complications, and diabetes with chronic complications); myocardial infarction; type 2 diabetes; arthritis; and alcohol abuse or dependence.

cDifference in means or proportions divided by standard error. Imbalance between the 2 groups was defined as absolute value greater than 0.10; smaller values indicated better balance.

dEstimated during the 12 months before the index date.

SD = standard deviation.